Why was a woman's coverage for a cancer drug denied?

A woman's public coverage for cancer drug Keytruda was denied, largely, it seems, on the basis that too few cancer patients have survived long enough to justify coverage beyond two years.

Guest: Richard Zussman - Global News Legislative Reporter 

Learn more about your ad choices. Visit megaphone.fm/adchoices